Simnotrelvir and ritonavir combo may shorten time to symptom resolution in patients with COVID-19: NEJM Medha Baranwal20 Jan 2024 10:45 AM ISTChina: A phase 2-3 trial revealed a shortened time to resolve symptoms among adult COVID-19 patients with early administration of simnotrelvir plus...
Low-dose calcium supplementation in pregnancy noninferior to high-dose supplementation for cutting risk of preeclampsia Dr. Kamal Kant Kohli12 Jan 2024 11:15 AM ISTIndia: Findings from two randomized trials showed low-dose calcium supplementation to be noninferior to high-dose calcium supplementation concerning...
Innovative screening blood test can identify genetic diseases in fetuses: NEJM Dr. Kamal Kant Kohli12 Jan 2024 6:00 AM ISTA research team from Odense University Hospital and the University of Southern Denmark has developed an innovative screening test. With a blood sample...
Marijuana Use highly Linked to Addiction, Psychosis: NEJM Niveditha Subramani3 Jan 2024 12:56 PM ISTThough Cannabis is legalized in few countries the usage of correct dose is not known. Heavy cannabis use has adverse effects on physical and mental...
Commonly prescribed rheumatoid arthritis drug baricitinib promising for type 1 diabetes patients: NEJM Dr. Kamal Kant Kohli8 Dec 2023 10:45 AM ISTAustralia: Ground-breaking research shows promise as the first disease-modifying treatment of its kind for type 1 diabetes that can be delivered as a...
Gantenerumab Shows Positive Outcome in Reducing Amyloid Plaque Burden: NEJM Jacinthlyn Sylvia4 Dec 2023 11:00 PM ISTThe two phase 3 trials, GRADUATE I and II, explored the potential of gantenerumab, a monoclonal antibody targeting amyloid-beta, in slowing cognitive...
IV levothyroxine infusion of no significant benefit in improving donor heart utilization from brain-dead donors: NEJM Medha Baranwal1 Dec 2023 6:00 AM ISTUSA: Intravenous (IV) levothyroxine infusion versus saline infusion failed to increase the rate of hearts transplanted from hemodynamically unstable...
Clinical trial results give new hope for children with rare gliomas Dr. Kamal Kant Kohli25 Nov 2023 10:30 AM ISTA collaboration of researchers, led by UCL and Great Ormond Street Hospital, have published successful results from a Phase II clinical trial for the...
Elafibranor Outperforms Placebo in Improving Biochemical Indicators of Cholestasis: NEJM Aditi22 Nov 2023 9:30 AM ISTPatients with primary biliary cholangitis who don't respond to standard therapy have a high risk of cirrhosis and poor quality of life. Previous...
Among bipolar I depression patients adjunctive antidepressant treatment beyond 8 weeks offers no significant benefit: NEJM Dr. Kamal Kant Kohli21 Nov 2023 4:45 PM ISTUSA: A recent study of patients with bipolar I disorder and a recently remitted depressive episode revealed that adjunctive treatment with...
Hypertonic saline stimulated copeptin reliably Diagnoses AVP deficiency in Polyuria Polydipsia Syndrome patients Jacinthlyn Sylvia19 Nov 2023 6:45 PM ISTA recent trial published in the New England Journal of Medicine shed light on the challenging diagnosis of arginine vasopressin (AVP) deficiency...
Semaglutide treatment benefits patients with heart failure and obesity: STEP-HFpEF trial Dr. Kamal Kant Kohli17 Nov 2023 10:45 AM ISTUSA: Obese patients with heart failure with preserved ejection fraction (HFpEF) treated with 2.4 mg semaglutide showed larger reductions in physical...
